MetLife Stock: Is Wall Street Bullish or Bearish?

Barchart
Abrir em Barchart
MetLife Stock: Is Wall Street Bullish or Bearish?

MetLife, Inc. (MET), headquartered in New York, is a global insurance and financial services company operating through subsidiaries and affiliates, with a market capitalization of $64.5 billion. The company holds leading market positions across the U.S., Japan, Latin America, Asia, Europe, the Middle East, and Africa, serving customers through a diverse range of insurance and financial solutions.

Shares of the global insurance giant have outperformed the broader market over the past year. MET has gained 29.2% during this period, compared with a 12.2% advance for the S&P 500 Index ($SPX). The stock has maintained its lead in 2026, gaining 30% year-to-date, while the S&P 500 has advanced 10.5% over the same period.

More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.

 

Likewise, MET has also outperformed the iShares U.S. Insurance ETF (IAK), which has climbed 14.6% over the past year and gained 12.5% year-to-date.

www.barchart.com

On Nov. 4, 2026, MetLife reported its third-quarter results, with shares rising 2.2% as investors digested the earnings report. Total revenue increased 18.2% year over year to $20.52 billion, while adjusted EPS rose 17.3% to $2.78. Adjusted premiums, fees, and other revenues, excluding pension risk transfers, increased 8.5% to $13.53 billion. At the segment level, Group Benefits’ adjusted earnings rose 14.7% to $523 million, while Asia’s adjusted earnings increased 11.5% to $602 million. However, Retirement and Income Solutions’ adjusted earnings declined 6.3% to $413 million, reflecting actuarial review adjustments.

MetLife reaffirmed that it remained on track to meet its full-year targets for its annual free cash flow ratio and direct expense ratio. The company also returned approximately $1 billion to shareholders during the quarter, including $650 million in share repurchases and $380 million in common stock dividends.

Analysts expect MET’s diluted EPS to increase 11.5% year over year to $9.91 for the fiscal year ending in December 2026. Meanwhile, the company has exceeded consensus EPS estimates in each of the past four quarters, reflecting a consistent track record of earnings beats.

Of the 19 analysts covering MET, the consensus rating is “Moderate Buy.” This assessment comprises 12 “Strong Buy” ratings, one “Moderate Buy” rating, and six “Hold” ratings.

www.barchart.com

This configuration reflects a more bullish outlook than two months ago, when the stock had 11 “Strong Buy” recommendations.

On Nov. 13, 2026, J.P. Morgan analyst Pablo Singzon maintained a “Buy” rating on MetLife and raised the price target from $110 to $112.

Based on analysts’ estimates, the mean price target of $112.41 implies a 9.5% premium to MET’s current share price, while the Street-high price target of $131 suggests a 27.6% upside.


On the date of publication, Abhishek Bhuyan did not directly have a position in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.

 

More news from Barchart

Why It’s Time to Load Up on CoreWeave Stock Dear AST SpaceMobile Stock Fans, Mark Your Calendars for November 17 Who Is Ian Buck? 10 Things to Know About the Nvidia Executive Investors Are Betting on to Replace Jensen Huang. Nvidia Fallout, Anthropic IPO and Other Can't Miss Items this Week